COPD the unseen factor causing increased morbidity and mortality among IHD patients

S. Das, S. Kundu, A. G. Ghoshal (Kolkata, India)

Source: Annual Congress 2009 - COPD case-finding and management in primary care
Session: COPD case-finding and management in primary care
Session type: Oral Presentation
Number: 1834
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Das, S. Kundu, A. G. Ghoshal (Kolkata, India). COPD the unseen factor causing increased morbidity and mortality among IHD patients. Eur Respir J 2009; 34: Suppl. 53, 1834

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004



Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021



Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009

COPD is an independent risk factor for mortality in community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018


Factors affecting mortality and morbidity in patients with bronchiectasis
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018



Cumulatively predicting cardiovascular hospitalisation and death in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021

MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Predictive factors of mortality in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007

Identifying risk groups for any cause hospitalizations in COPD patients
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003


Risk factors of mortality in COPD patients with ventilator associated pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 50s
Year: 2007

Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020